Pre-earnings options volume in Sana Biotechnology (SANA) is normal with calls leading puts 481:1. Implied volatility suggests the market is anticipating a move near 5.3%, or 18c, after results are released. Median move over the past eight quarters is 2.7%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SANA:
- Sana Biotechnology Rebalances Board Classes With Director Shift
- Sana Biotechnology price target raised to $7 from $6 at Wedbush
- Sana Biotechnology: Mayo Clinic Collaboration and UP421 Data De‑Risk SC451 and Support Buy Rating on Type 1 Diabetes Momentum
- Sana Biotechnology Secures Strategic Equity Investment from Mayo
- Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic